Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Effects of recombinant leptin therapy in a child with congenital leptin deficiency

Article Abstract:

Leptin treatment may be beneficial for obese children. Leptin is a hormone involved in regulating body weight. Researchers treated a 9-year-old girl with leptin deficiency with daily injections of recombinant leptin. At the beginning of therapy, she weighed 207 pounds. During the one-year treatment, she lost about 36 pounds at the rate of 2 to 4 pounds per month. Her fat mass dropped considerably but her lean body mass increased. Her basal metabolic rate also decreased 18%, but she became more physically active. Her body produced antibodies against the injected leptin but the antibodies did not seem to change the effectiveness of the treatment.

Author: Farooqi, I. Sadaf, O'Rahilly, Stephen, Hughes, Ieuan A., Prentice, Andrew M., McCamish, Mark A., Jebb, Susan A., Cheetham, Christopher H., Langmack, Gill, Lawrence, Elizabeth (American landscape architect)
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1999
Health aspects, Care and treatment, Leptin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene

Article Abstract:

A mutation in the gene for the melanocortin 4 receptor appears to be one cause of obesity, according to a study of 500 obese children. This gene codes for the receptor for an enzyme called alpha melanocyte-stimulating hormone. The hormone causes a decrease in food consumption. The mutation would create a defective receptor, which could interfere with the proper function of the hormone.

Author: Farooqi, I. Sadaf, O'Rahilly, Stephen, Keogh, Julia M., Yeo, Giles S.H., Lank, Emma J., Cheetham, Tim
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
Intermedin, Melanocyte stimulating hormone

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Melanocortin receptors weigh in

Article Abstract:

The melanocortin-4 receptor (MC4R) that is highly expressed in the brain acts as a central regulator of food intake and fat mass. The studies confirming the MC4R links to obesity is presented.

Author: Farooqi, I. Sadaf, O'Rahilly, Stephen, Yeo, Giles S.H.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2004
United States, Science & research, Biological Product (except Diagnostic) Manufacturing, Drugs, Biological Processors, Bioreactors, Research, Gene mutations, Gene mutation, Obesity

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Obesity in children, Childhood obesity, Genetic aspects
Similar abstracts:
  • Abstracts: The effect of finasteride in men with benign prostatic hyperplasia. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
  • Abstracts: Effects of vesnarinone on morbidity and mortality of patients with heart failure. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
  • Abstracts: Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States
  • Abstracts: Association of two loci on chromosome 2q with nodal osteoarthritis. Radiographic assessment of patellofemoral osteoarthritis
  • Abstracts: Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. Parathyroid hormone-related protein levels in maternal and cord blood
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.